No results for ‘’
Nureca Ltd
₹282.46
(0.95%)
Mon, 27 Jul 2026, 00:24 pm
Health Technology
Medical Specialties
24.5KNureca EV/EBITDA Ratio
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 9.71 | 30.30 | 0 | 0 | 248.64 |
| Price to book ratio | 0 | 0 | 0 | 3.69 | 6.70 | 1.54 | 1.32 | 1.08 |
| Price to sales ratio | 0 | 0 | 0 | 2.11 | 5.33 | 2.70 | 2.78 | 1.92 |
| Price to cash flow ratio | 0 | 0 | 0 | 13.17 | 272.15 | 26.49 | 37.91 | 0 |
| Enterprise value | 0 | 0 | 0 | 327Cr | 1249Cr | 172Cr | 114Cr | 86.89Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 5.22 | 21.47 | 0 | 0 | 0 |
| Debt to equity ratio | 0 | 0.05 | 0.65 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 |
| Return on equity % | 0 | 128.84 | 55.90 | 52.10 | 24.55 | -4.14 | -0.92 | 0.44 |
Nureca Ltd Enterprise Value to EBITDA Ratio
The Nureca Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Nureca Ltd's valuation, profitability, and overall financial performance. Tracking the Nureca Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Nureca Ltd (NSE: NURECA, BSE: 543264) is currently trading at ₹282.46, with a market capitalization of ₹265.79Cr. As a leading company in the Health technology sector and Medical specialties industry, monitoring the Nureca Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Nureca Ltd Enterprise Value to EBITDA Ratio Current Value
The current Nureca Ltd Enterprise Value to EBITDA Ratio stands at 0.
The Nureca Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.
Nureca Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Nureca Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 21.47
- 2020: 5.22
The decline in Nureca Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Nureca Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Nureca Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Nureca Ltd.
Nureca Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Nureca Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Nureca Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Nureca Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.